Arthroscopic Transplantation of Synovial Stem Cells Improves Clinical Outcomes in Knees With Cartilage Defects.
Arthroscopic Transplantation of Synovial Stem Cells Improves Clinical Outcomes in Knees With Cartilage Defects.
复制标题
DOI：
10.1007/s11999-015-4324-8
复制
发表时间：
2015-07
影响因子：
4.2
通讯作者：
Koga, Hideyuki
中科院分区：
文献类型：
--
作者：
Sekiya, Ichiro;Muneta, Takeshi;Horie, Masafumi;Koga, Hideyuki
间充质干细胞（MSCs）移植是实现关节软骨修复的一种可能策略。我们以前报道过滑膜间充质干细胞是高度增殖的，能够发生软骨形成。我们还发现，在兔和猪模型中，将滑膜间充质干细胞悬浮液放置在软骨缺损上10分钟可促进软骨修复。然而，这种方法的体内疗效尚未经过临床试验。我们询问滑膜间充质干细胞移植是否能改善(1)膝关节软骨缺损患者的MRI特征、(2)组织学特征和(3)临床评价评分？在2008年4月至2011年4月期间，有10例股骨髁单软骨病变的患者被纳入我们的研究。所有患者均完成了3年或更长时间的随访。平均随访52个月（37 ~ 80个月）。消化后用10%的自体人血清扩增滑膜间充质干细胞14天。移植时，患者体位使软骨缺损面朝上，在关节镜控制下，用注射器将滑膜间充质干细胞悬浮液置于软骨缺损处。然后将应用悬浮液的缺陷保持在向上的位置10分钟。5例患者同时行前交叉韧带重建，其中2例同时行半月板缝合。对于MRI量化，软骨缺损评分从0到5。对4例患者进行二次关节镜检查，并对活检标本进行组织学评估。临床结果在最后随访时使用Lysholm评分和Tegner活动水平量表进行评估。使用Wilcoxon符号秩检验对每位患者治疗前后的MRI和Lysholm评分进行比较分析。MRI评分（中位±95% CI）治疗前为1.0±0.3，治疗后为5.0±0.7，治疗后均升高（p = 0.005）。四例患者的二次关节镜检查显示，所有病例的软骨缺损在质量上都较好。组织学分析显示3例患者可见透明软骨，1例患者可见深层纤维软骨。治疗前Lysholm评分（中位±95% CI）为76±7，治疗后为95±3，治疗后各患者Lysholm评分均升高（p = 0.005）。每位患者治疗后Tegner活动水平量表均未下降。在这个小的初始病例系列中，滑膜间充质干细胞移植在MRI评分、定性组织学和Lysholm评分方面是有效的。使用滑膜间充质干细胞的优势在于，细胞可以在14天内通过0代制备。滑膜间充质干细胞移植可能比镶嵌成形术和自体软骨细胞植入侵入性小。为了最终证明这种治疗的有效性，需要进行比较研究，特别是与更成熟的关节镜手术，如骨髓刺激技术进行比较研究。四级，治疗性研究。
Transplantation of mesenchymal stem cells (MSCs) is one possible strategy to achieve articular cartilage repair. We previously reported that synovial MSCs were highly proliferative and able to undergo chondrogenesis. We also found that placing a suspension of synovial MSCs on a cartilage defect for 10 minutes promoted cartilage repair in rabbit and pig models. However, the in vivo efficacy of this approach has not been tested clinically. We asked whether transplantation of synovial MSCs improves (1) MRI features, (2) histologic features, and (3) clinical evaluation scores in patients with cartilage defects in the knee? Patients with a symptomatic single cartilage lesion of the femoral condyle were indicated for inclusion in our study, and between April 2008 and April 2011, 10 patients were enrolled in this study. All patients completed followups of 3 years or more. The average followup period was 52 months (range, 37–80 months). Synovial MSCs were expanded with 10% autologous human serum for 14 days after digestion. For transplantation, the patient was positioned so that the cartilage defect was facing upward, and synovial MSC suspension was placed on the cartilage defect with a syringe under arthroscopic control. The defect with the applied suspension then was held in the upward position for 10 minutes. Five patients underwent concomitant ACL reconstructions, among whom two had meniscus suturing performed simultaneously. For MRI quantification, the cartilage defect was scored from 0 to 5. Second-look arthroscopy was performed for four patients and biopsy specimens were evaluated histologically. Clinical outcome was assessed using the Lysholm score and Tegner Activity Level Scale at final followup. Comparisons of MRI and Lysholm scores before and after treatment for each patient were analyzed using the Wilcoxon signed-rank test. MRI score (median ± 95% CI) was 1.0 ± 0.3 before and 5.0 ± 0.7 after, and increased after treatment in each patient (p = 0.005). Second-look arthroscopy in four patients showed that the cartilage defect appeared to be qualitatively better in all cases. Histologic analyses showed hyaline cartilage in three patients and fibrous cartilage in one at the deep zone. The Lysholm score (median ± 95% CI) was 76 ± 7 before and 95 ± 3 after, and increased after treatment in each patient (p = 0.005). The Tegner Activity Level Scale did not decrease after treatment in each patient. For this small initial case series, transplantation of synovial MSCs was effective in terms of MRI score, qualitative histology, and Lysholm score. The use of synovial MSCs has an advantage in that the cells can be prepared at passage 0 in only 14 days. Transplantation of synovial MSCs may be less invasive than mosaicplasty and autologous chondrocyte implantation. To conclusively show the effectiveness of this treatment requires comparative studies, especially with more established arthroscopic procedures, such as marrow stimulation techniques. Level IV, therapeutic study.
登录
查看更多内容
影响因子：
4.2
作者：
Matsukura Y;Muneta T;Tsuji K;Koga H;Sekiya I
通讯作者：
Sekiya I
影响因子：
5.2
作者：
Koga, Hideyuki;Muneta, Takeshi;Sekiya, Ichiro
通讯作者：
Sekiya, Ichiro
影响因子：
3.6
作者：
Koga, Hideyuki;Muneta, Takeshi;Sekiya, Ichiro
通讯作者：
Sekiya, Ichiro
影响因子：
--
作者：
Wakitani, S;Goto, T;Caplan, AI
通讯作者：
Caplan, AI
影响因子：
4.8
作者：
LYSHOLM, J;GILLQUIST, J
通讯作者：
GILLQUIST, J